Health Equity Accelerator Awards

Diverse and underserved populations lack equitable access to medicines, care, support and education. Sanofi is committed to improving health equity in underserved communities. As part of our commitment, Sanofi is recognizing and accelerating solutions and ideas through the Health Equity Accelerator Awards that bridge gaps in access to care.

Sanofi U.S. is Excited to Launch the Health Equity Accelerator Awards!

Overview of Sanofi Health Equity Accelerator Awards

Diverse and underserved populations lack equitable access to medicines, care, support, and education. These gaps are particularly evident in atrial fibrillation (AFib), diabetes, and the transplant community. Below are some of the ways these inequities can manifest to negatively impact people:

Atrial Fibrillation  
  • Racial disparities in people’s awareness and treatment of Afib
  • Black Americans are less likely to be treated for Afib and more likely to have a stroke
  • Women with arrhythmias in the US are under-treated and under-referred
Diabetes
  • There are stark racial disparities in prevalence and incidence of diabetes across the US
  • Racial and ethnic minority populations bear a higher burden of diabetes-related complications
Transplant
  • Fifty percent of US patients awaiting kidney transplantation are ethnic minorities
  • Minorities are more likely to need a transplant but less likely to receive one
  • Minorities are less likely to donate an organ
  • Black Americans are disproportionately affected by multiple myeloma and less likely to receive stem cell transplants

These inequities are exacerbated by bias and mistrust in the US healthcare system and social determinants of health leading to multiple chronic conditions, among other factors. The COVID-19 pandemic worsened existing health disparities but also led to a heightened public awareness of these realities.

At Sanofi, we believe every person has the right to a fair and just opportunity to be as healthy as possible and no one should be disadvantaged from getting the care they deserve. Our CEO Paul Hudson has stated, “We have a clear responsibility as a company to play our part in building a fairer, more equitable and inclusive society. We can drive sustainable change inside our company and within our communities.”

We have been working on improving equity in the underserved communities and bridging the health disparity gap for many years. As part of our responsibility, we want to identify, reward, support, and share efforts that improve health equity and overcome health disparities for the transplant community, for people living with atrial fibrillation, and people living with diabetes.

The goal is to accelerate health equity solutions that overcome health disparities for the transplant community, for people living with AFib, and people living with diabetes, with a specific focus on the following three challenges:

1 Atrial Fibrillation   Ensure women and black Americans have equitable access to education about the signs and symptoms of atrial fibrillation and the need for appropriate treatment
2 Diabetes Ensure minoritized people living with diabetes, including seniors, receive treatment, services, and educational support in line with national guidelines
3 Transplant Ensure minoritized populations receive equitable opportunities for stem cell and solid organ transplantation as well as education on the importance of organ and stem cell donation

 

How it works

Only 501c(3) organizations may apply for the Health Equity Accelerator Award. The application deadline is Friday, September 30, 2022 at 5:00 p.m. EST. Applications that are incomplete or missing content, or posted after the deadline will not be considered for the award.

If you cannot download the application and need a copy sent to you directly, please reach out to HealthEquityAwards@sanofi.com.

A panel of judges consisting of two independent thought leaders with expertise on improving health equity and one senior leader from Sanofi’s US Diversity, Equity and Inclusion team will determine the winners. The panel will review the applications and choose up to three (3) recipients, one in each area of AFib, diabetes, and transplant.

The winners will receive the following:

  • $50,000 award to each winner*
  • Participation in the Health Equity Accelerator Awards ceremony, which will be held in November 2022
  • Public recognition through press releases and social media

Recipients have no obligation to Sanofi.

*Subject to certain limitations and review required by company policy.

Eligibility

Requirements for applicants and award recipients of the Sanofi Health Equity Accelerator Awards program are listed below.

  • Applicant must have made a significant health equity contribution to the community on behalf of atrial fibrillation, diabetes, and/or transplant patients (e.g., access to delivery of care, education, medicine, technology or other aspects of US healthcare system).
  • Organizations must be designated as 501c(3) not-for-profit
  • US focused solutions only
  • Each solution must be submitted as a separate application.
  • There is no limit to the number of applications a single organization can submit for consideration.
  • Solution can be implemented alone or in partnership with multiple organizations. Only one application should be submitted by a single organization on behalf of all those linked to the solution.
  • If selected as a winner, the lead organization must meet the organizational requirements and would receive the financial award.
  • The application must have been submitted prior to the program closing deadline, September 30, 2022 at 5:00 p.m. EST.
  • All applications must be submitted electronically.
  • Applicants must agree to be recognized and promoted through all channels as part of the Health Equity Accelerator Awards program.
  • Employees, former employees, or relatives of Sanofi employees may not submit an application for the award.
  • Research projects will not be considered.
  • Solutions selected to receive a Health Equity Accelerator Award are ineligible for future Health Equity Accelerator Awards.
Selection Criteria

The program will select winners based on the evaluation of the application, the letter detailing the solution, any supporting evidence and the extent to which the applying organization embodies the goals of the Health Equity Accelerator Awards program.

The judges will determine the 3 winning solutions, one each in AFib, diabetes, and transplant.

The panel will determine who best:

  • Met the stated goals to accelerate health equity solutions
    • Ensure women and black Americans have equitable access to education about the signs and symptoms of atrial fibrillation and the need for appropriate treatment
    • Ensure minoritized people living with diabetes, including seniors, receive treatment, services, and educational support in line with national guidelines
    • Ensure minoritized populations receive equitable opportunities for stem cell and solid organ transplantation as well as education on the importance of organ and stem cell donation
  • Demonstrated significant health equity contribution or ability to have a quantifiable impact
  • Showed their solution to be most replicable, scalable, and sustainable to expand its impact for patients

Based on the applications received, every effort will be made, but not guaranteed, to identify at least one recipient in each disease area who is making an impact on health equity.

Application Information

To be considered, an organization must submit a completed application by emailing it to HealthEquityAwards@sanofi.com. The email must be timestamped before, Friday, September 30, 2022 at 5:00 p.m. EST.

The application is available as a separate download by clicking on the link below or by emailing HealthEquityAwards@sanofi.com.

Applications should include as an attachment to this application an essay or letter addressing the topics below, along with any supporting documentation and other information that is important for the judges to consider.

  1. Define the health equity problem(s) being solved
  2. Describe the solution including target audience, approach or process, objectives
  3. Demonstrate measurable impact achieved as a direct result of the solution
  4. Provide details of the plan including how the program will be expanded, replicated and/or scaled. This includes how funding will be utilized.